Mechanisms of selective motor neuron death in ALS: Insights from transgenic mouse models of motor neuron disease

Neuropathology and Applied Neurobiology

Volumn 22, Issue 5, 1996, Pages 373-387

  Bruijn, L I ^a   Cleveland, D W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyotrophic lateral sclerosis; Cu Zn superoxide dismutase; Neurofilaments; Transgenic mouse models

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOTHESIS; MOTOR NEURON DISEASE; MOUSE; NEUROFILAMENT; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

EID: 0029969678     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1996.tb00907.x     Document Type: Review

References (73)

1. Banker BQ, Engel AG, Banker BQ, Eds. Myology: the Pathology of the Motor Neuron Diseases. New York: McGraw-Hill, 1986: 2031-66
2. Beckman JS, Carson M, Smith CD, Koppenol WH, ALS, SOD and peroxynitrite. Nature 1993; 364: 584
3. Borchelt DR, Guarnieri M, Wong PC et al. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J Biol Chem 1995; 270: 3234-8
4. Borchelt DR, Lee MK, Slunt HS et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994; 91: 8292-6
5. Bowling AC, Schulz JB, Brown RH, Jr, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 61: 2322-5
6. Brown RH, Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80: 687-92
7. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology 1968; 18: 841-51
8. Ching GY, Liem RK. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J Cell Biol 1993; 122: 1323-35
9. Chou SM, Tsubaki T, Toyokura Y, Eds. Amyotrophic Lateral Sclerosis: Proceedings of the International Symposium on ALS. Pathology of Intraneuronal Inclusions in ALS. Baltimore: University Park Press, 1979: 135-76
10. Chou SM, Fakadej AV. Ultrastructure of chromatolytic motor neurons and anterior spinal roots in a case of Werdnig-Hoffman disease. J Neuropathol Exp Neurol 1971; 30: 42-55
11. Chou SM, Norris FH. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. [Review]. Muscle Nerve 1993; 16: 864-9
12. Cleveland DW, Laing N, Hurse PV, Brown RH. Toxic mutants in Charcot's sclerosis. Nature 1995; 378: 342-3
13. Collard JF, Cote F, Julien JP. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995; 375: 61-1
14. Cote F, Collard JF, Julien JP. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 1993; 73: 35-46
15. Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994; 145: 1271-9
16. Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995; 676: 25-40
17. de Waegh SM, Lee VM, Brady ST. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 1992; 68: 451-63
18. Delisle MB, Carpenter S. Neurofibrillary axonal swellings and amyotropic lateral sclerosis. J Neurol Sci 1984; 63: 241-50
19. Deng H-X, Hentati A, Tainer JA et al Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 1993; 261: 1047-51
20. Elhanany E, Jaffe H, Link WT, Sheeley DM, Gainer H, Pant HC. Identification of endogenously phosphorylated KSP sites in the high-molecular-weight rat neurofilament protein. J Neurochem 1994; 63: 2324-35
21. Eyer J, Peterson A. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein. Neuron 1994; 12: 389-405
22. Figlewicz DA, Krizus A, Martinoli MG et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 1757-61
23. Figlewicz DA, Rouleau GA, Krizus A, Julien JP. Polymorphism in the multi-phosphorylation domain of the human neurofilament heavy-subunit-encoding gene. Gene 1993; 132: 297-300
24. Friede RL, Samorajski T. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibres of rats and mice. Anat Rec 1970; 167: 379-87
25. Geisler N, Weber K. Self-assembly in vitro of the 68 000 molecular weight component of the mammalian neurofilament triplet proteins into intermediate-sized filaments. J Mol Biol 1981; 151: 565-71
26. Gonatas NK, Stieber A, Mourelatos Z et al. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol 1992; 140: 731-7
27. Greenlund LJ, Deckwerth TL, Johnson EM, Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995; 14: 303-15
28. Gurney ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772-5
29. Hirano A, Rowland LP, Eds. Advances in Neurology, Vol. 56. Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases. Cytopathology of amyotrophic lateral sclerosis. New York: Raven Press, 1991: 91-101
30. Hirano A, Donnenfeld H, Sasaki S, Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1984; 43: 461-70
31. Hirano A, Nakano I, Kurland LT, Mulder DW, Holley PW, Saccomanno G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1984; 43: 471-80
32. Hirokawa N, Glicksman MA, Willard MB. Organization of mammalian neurofilament polypeptides within the neuronal cytoskeleton. J Cell Biol 1984; 98: 1523-36
33. Hisanaga S, Hirokawa N. Structure of the peripheral domains of neurofilaments revealed by low angle rotary shadowing. J Mol Biol 1988; 202: 297-305
34. Hoffman PN, Cleveland DW, Griffin JW, Landes PW, Cowan NJ, Price DL. Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci USA 1987; 84: 3472-6
35. Hsieh S-T, Kidd GJ, Crawford TO, Xu Z-S, Trapp BD, Cleveland DW, Griffin JW. Regional modulation of neurofilament organization by myelination in normal axons. J Neurosci 1994; 14: 6392-401
36. Kato S, Oda M, Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral scleroisis. Neuropathol Applied Neurobiol 1993; 19: 300-4
37. Kawamura Y, Dyck PJ, Shimono M, Okazaki H, Tateishi J, Doi H. Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1981; 40: 667-75
38. Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease. Neuron 1994; 13: 975-88
39. Lee MK, Xu Z, Wong PC, Cleveland DW. Neurofilaments are obligate heteropolymers in vivo. J Cell Biol 1993; 122: 1337-50
40. Lees JF, Shneidman PS, Skuntz SF, Carden MJ, Lazzarini RA. The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it. EMBO J 1988; 7: 1947-55
41. Leigh PN, Swash M. Cytoskeletal pathology in motor neuron diseases. Adv Neurol 1991; 56: 115-24
42. Leigh PN, Whitwell H, Garofalo O et al. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 1991; 114: 775-88
43. Liem RK, Hutchison SB. Purification of individual components of the neurofilament triplet: filament assembly from the 70 000-dalton subunit. Biochemistry 1982; 21: 3221-6
44. McCord JM. Superoxide radical: controversies, contradictions, and paradoxes. Proc Soc Exp Biol Med 1995; 209: 112-7
45. Mizutani T, Sakamaki S, Tsuchiya N et al. Amyotrophic lateral sclerosis with opthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol 1992; 84: 372-7
46. 45a Mourelatos Z, Gonatas NK, Stieber A, Gurney ME, Dal Canto MC. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early preclinical stages of the disease. Proc Nat Acad Sci 1996; 93: 5472-7
47. Mulligan L, Balin BJ, Lee VM, Ip W. Antibody labeling of bovine neurofilaments: implications on the structure of neurofilament sidearms. J Struct Biol 1991; 106: 145-60
48. Nakano Y, Hirayama K, Terao K. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch Neurol 1987; 44: 103-6
49. Nixon RA, Paskevich PA, Sihag RK, Thayer CY. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber. J Cell Biol 1994; 126: 1031-46
50. Ohara O, Gahara Y, Miyake T, Teraoka H, Kitamura T. Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene. J Cell Biol 1993; 121: 387-95
51. Orrell R, Belleroche J, Marklund S, Bowe F, Hallewell R. A novel SOD mutant and ALS. Nature 1995; 374: 504-5
52. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 1995; 92: 954-8
53. Pogun S, Dawson V, Kuhar MJ. Nitric oxide inhibits h-glutamate transport in synaptosomes. Synapse 1994; 18: 21-6
54. Reaume A, Elliott JL, Hoffman EK et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet 1996; 13: 43-7
55. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995; 92: 689-93
56. Robberecht W, Sapp P, Viaene MK et al. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1994; 62: 384-7
57. 55a Rooke K, Figlewicz DA, Han F, Rouleau GA. Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis. Ann Neurol 1996; 46: 789-90
58. Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotropic lateral sclerosis. Nature 1993; 362: 59-62
59. Rothstein JD, Bristol LA, Hosler B, Brown RH, Jr, Kunel RW. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 1994; 91: 4155-9
60. Rouleau G, Clark AW, Rooke K et al. SOD1 Mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurology 1996; 39: 128-31
61. 58a Shibata NA, Hirano A, Kobayashi M, Siddique T, Deng H-X, Hung W-Y, Kato T, Asayama K. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 1996; 55: 481-90
62. Sakaguchi T, Okada M, Kitamura T, Kawasaki K. Reduced diameter and conduction velocity of myelinated fibres in the sciatic nerve of a neurofilament-deficient mutant quail. Neurosci Lett 1993; 153: 65-8
63. Tsuda T, Muthasser S, Fraser PE et al. Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron 1994; 13: 727-36
64. 60a Tu P-H, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM-Y. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human anyotrophic lateral sclerosis lesions. Proc Nat Acad Sci 1996; 93: 3155-60
65. Verge VMK, Xu Z, Xu X-J, Wiesenfeld-Hallin Z, Hokfelt T. Marked increase in nitric oxide synthase mRNA in rat dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. Proc Natl Acad Sci USA 1992; 89: 11617-21
66. 61a Vechio JV, Bruijn LI, Xu Z-S, Brown Jr RH, Cleveland DW. Identification of variants in human neurofilament genes: absence of linkage to familial ALS. Ann. Neurol. 1996: in press.
67. Wiedau-Pazos M, Goto JJ, Rabizadeh S et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral scleorsis. Science 1996; 271: 515-8
68. Wiley CA, Love S, Skoglund RR, Lampert PW. Infantile neurodegenerative disease with neuronal accumulation of phosphorylated neurofilaments. Acta Neuropathol (Berl) 1987; 72: 369-76 0
69. Wong PC, Marszalek J, Crawford TO et al. Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons. J Cell Biol 1995; 130: 1413-22
70. Wong PC, Pardo CA, Borchelt DR et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vaculolar degeneration of mitochondria. Neuron 1995; 14: 1105-16
71. Xu Z, Cork LC, Griffin JW, Cleveland DW. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 1993; 73: 23-33
72. Xu ZS, Liu WS, Willard M. Identification of serine 473 as a major phosphorylation site in the neurofilament polypeptide NF-L. J Neurosci 1990; 10: 1838-46
73. Yamasaki H, Bennett GS, Itakura C, Mizutani M. Defective expression of neurofilament protein subunits in hereditary hypotrophic axonopathy of quail. Lab Invest 1992; 66: 734-43